Picture of Bioventus logo

BVS Bioventus News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapSuper Stock

Bioventus Inc reports results for the quarter ended in September 30 - Earnings Summary

* Bioventus Inc  BVS.OQ  reported quarterly adjusted
earnings of 6
cents​​ per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported EPS
of 5 cents.  The mean expectation of three analysts for the
quarter was for earnings of 3 cents per share. Wall Street
expected results to range from 1 cents to 6 cents per share.
    * Revenue rose 15% to $138.96 million from a year ago;
analysts
expected $133.23 million. 
    * Bioventus Inc's reported EPS for the quarter was a loss
of 7
cents​.
    * The company reported a quarterly loss of $4.82 million.
    * Bioventus Inc shares had fallen by 3.9% this quarter and
gained 117.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 18.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "hold"

Wall Street's median 12-month price target for Bioventus Inc is
15.00 
This summary was machine generated from LSEG data November 6 at
05:04 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      0.03           0.06           Beat
 Jun. 30 2024      0.07           0.19           Beat
 Mar. 31 2024      -0.07          0.07           Beat
 Dec. 31 2023      0.02           0.07           Beat

Recent news on Bioventus

See all news